Not only are prostate cancer rates in New Jersey among the highest in the country, but there are few hospital-based urology cancer research programs available here, which makes the Foundation’s goal of raising $500,000 for a new Urology Cancer Research Program sweet news to many.
Physicians at Garden State Urology (GSU) have raised $50,000 toward the program this spring.
“This initiative is an important component of giving our patients comprehensive care,” says Arthur Israel, MD, a partner in the practice and director of the hospital’s Men’s Cancer Center. “Urological cancers are on the increase, which makes this a timely endeavor.”
In 2015, bladder, kidney and prostate cancers claimed the lives of 60,000 nationwide, with 356,000 new diagnoses projected for 2016.
“Despite this fast growth in cancer rates, funding for research has decreased dramatically,” says Dr. Israel.
The Morristown program will focus on disease detection, prevention and treatment. Patients will gain access to clinical trials to test new drug, surgical and medical device interventions.
For additional information, contact Cynthia W. O’Donnell, JD, director of gift planning, at 973-593-2418 or email@example.com
Pictured (l-r) Rosemary Stefiniw, RN, manager, Oncology, Urology, Pulmonary and Sports Research Data and Outcomes; Dr. Arthur Israel; and Darlene Wendling, RN, nurse coordinator, Oncology Research